Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma
Autor: | Luya Cai, Shanshan Yu, Ruihong Gu, Leying Zhuo, Chuan Liu, Lingyi Cai |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Oncology
Adult Male medicine.medical_specialty Stromal cell Carcinoma Hepatocellular Adolescent Hepatocellular carcinoma Carcinogenesis medicine.medical_treatment Kaplan-Meier Estimate lcsh:Biochemistry Young Adult Immune system Internal medicine Genetics medicine Tumor Microenvironment Humans lcsh:QD415-436 Molecular Biology Survival rate Genetics (clinical) Aged Proportional Hazards Models Aged 80 and over Tumor microenvironment Proportional hazards model business.industry lcsh:RM1-950 Liver Neoplasms Immunotherapy Middle Aged medicine.disease Prognosis Molecular medicine Gene Expression Regulation Neoplastic Alternative Splicing lcsh:Therapeutics. Pharmacology Immune microenvironment Molecular Medicine Female business Research Article |
Zdroj: | Molecular Medicine Molecular Medicine, Vol 27, Iss 1, Pp 1-15 (2021) |
ISSN: | 1528-3658 1076-1551 |
Popis: | Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world, and its 5-year survival rate is less than 20%, despite various treatments being available. Increasing evidence indicates that alternative splicing (AS) plays a nonnegligible role in the formation and development of the tumor microenvironment (TME). However, the comprehensive analysis of the impact on prognostic AS events on immune-related perspectives in HCC is lacking but urgently needed. Methods The transcriptional data and clinical information of HCC patients were downloaded from TCGA (The Cancer Genome Atlas) database for calculating immune and stromal scores by ESTIMATE algorithm. We then divided patients into high/low score groups and explored their prognostic significance using Kaplan–Meier curves. Based on stromal and immune scores, differentially expressed AS events (DEASs) were screened and evaluated with functional enrichment analysis. Additionally, a risk score model was established by applying univariate and multivariate Cox regression analyses. Finally, gene set variation analysis (GSVA) was adopted to explore differences in biological behaviors between the high- and low-risk subgroups. Results A total of 370 HCC patients with complete and qualified corresponding data were included in the subsequent analysis. According to the results of ESTIMATE analysis, we observed that the high immune/stromal score group had a longer survival probability, which was significantly correlated with prognosis in HCC patients. In addition, 467 stromal/immune score-related DEASs were identified, and enrichment analysis revealed that DEASs were significantly enriched in pathways related to HCC tumorigenesis and the immune microenvironment. More importantly, the final prognostic signature containing 16 DEASs showed powerful predictive ability. Finally, GSVA demonstrated that activation of carcinogenic pathways and immune-related pathways in the high-risk group may lead to poor prognosis. Conclusions Collectively, these outcomes revealed prognostic AS events related to carcinogenesis and the immune microenvironment, which may yield new directions for HCC immunotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: |